Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshad Farzadfar

Showing results (21-30 of 368) with videos related to

Pageof 37
Sort By:
Plos One|September 11, 2025
Spatiotemporal disparity of breast cancer incidence in Iranian female populations at the district level from 2000 to 2021: Bayesian disease mappingShadi Rahimzadeh, James Bentham, Beata Burczynska, et al.
Plos One|February 15, 2019
Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling studyFatemeh Khosravi Shadmani, Farshad Farzadfar, Bagher Larijani, et al.
Journal of Diabetes and Metabolic Disorders|March 24, 2017
Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment modelsMehran Shams-Beyranvand, Farshad Farzadfar, Shohreh Naderimagham, et al.
Medical Journal of the Islamic Republic of Iran|January 22, 2016
Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in IranAlireza Ahmadvand, Farshad Farzadfar, Hamid Reza Jamshidi, et al.
The International Journal on Drug Policy|March 3, 2015
People who inject drugs in prison: HIV prevalence, transmission and preventionKate Dolan, Babak Moazen, Atefeh Noori, et al.
BMC Public Health|December 14, 2022
Inequality in prevalence, awareness, treatment, and control of hypertension in Iran: the analysis of national households' dataMahdi Mahdavi, Mahboubeh Parsaeian, Farshad Farzadfar, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|February 4, 2021
Human resources for health density and its associations with child and maternal mortality in the Islamic Republic of IranZahra Madadi, Farhad Pishgar, Erfan Ghasemi, et al.
Archives of Iranian Medicine|February 16, 2020
Improved Population Health in Iran from 1979 to 2019; Decreasing Mortality Rates and Increasing Life ExpectancyNarges Ebrahimi, Parinaz Mehdipour, Farnam Mohebi, et al.
Archives of Iranian Medicine|November 21, 2022
Prevalence and Determinants of Severe Mental Disorders in Iran: Evidence from the National Survey of STEPs- 2016Farshad Farzadfar, Rostam Zalvand, Badrye Karami, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|October 22, 2015
Prevalence of dyslipidemia in Iranian children and adolescents: A systematic reviewSilva Hovsepian, Roya Kelishadi, Shirin Djalalinia, et al.
Pageof 37

Showing results (21-30 of 368) with videos related to

Sort By:
Pageof 37
Plos One|September 11, 2025
Spatiotemporal disparity of breast cancer incidence in Iranian female populations at the district level from 2000 to 2021: Bayesian disease mappingShadi Rahimzadeh, James Bentham, Beata Burczynska, et al.
Plos One|February 15, 2019
Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling studyFatemeh Khosravi Shadmani, Farshad Farzadfar, Bagher Larijani, et al.
Journal of Diabetes and Metabolic Disorders|March 24, 2017
Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment modelsMehran Shams-Beyranvand, Farshad Farzadfar, Shohreh Naderimagham, et al.
Medical Journal of the Islamic Republic of Iran|January 22, 2016
Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in IranAlireza Ahmadvand, Farshad Farzadfar, Hamid Reza Jamshidi, et al.
The International Journal on Drug Policy|March 3, 2015
People who inject drugs in prison: HIV prevalence, transmission and preventionKate Dolan, Babak Moazen, Atefeh Noori, et al.
BMC Public Health|December 14, 2022
Inequality in prevalence, awareness, treatment, and control of hypertension in Iran: the analysis of national households' dataMahdi Mahdavi, Mahboubeh Parsaeian, Farshad Farzadfar, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|February 4, 2021
Human resources for health density and its associations with child and maternal mortality in the Islamic Republic of IranZahra Madadi, Farhad Pishgar, Erfan Ghasemi, et al.
Archives of Iranian Medicine|February 16, 2020
Improved Population Health in Iran from 1979 to 2019; Decreasing Mortality Rates and Increasing Life ExpectancyNarges Ebrahimi, Parinaz Mehdipour, Farnam Mohebi, et al.
Archives of Iranian Medicine|November 21, 2022
Prevalence and Determinants of Severe Mental Disorders in Iran: Evidence from the National Survey of STEPs- 2016Farshad Farzadfar, Rostam Zalvand, Badrye Karami, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|October 22, 2015
Prevalence of dyslipidemia in Iranian children and adolescents: A systematic reviewSilva Hovsepian, Roya Kelishadi, Shirin Djalalinia, et al.
Pageof 37